The clinical analysises of percutaneous mechanical thrombectomy apply to vascular disease
10.3760/cma.j.issn.1673-4203.2015.12.017
- VernacularTitle:经皮机械血栓旋切术在下肢血管疾病中的临床分析
- Author:
Junli ZHUANG
;
Ye YAO
;
Jingbo LI
;
Tong JIAO
;
Qingfeng SUN
;
Haiyang WANG
- Publication Type:Journal Article
- Keywords:
Arteriosclerosis obliterans;
Thrombosis;
Percutaneous mechanical thrombectomy;
SilverHawk/TurboHawk system;
Straub rotarex system
- From:
International Journal of Surgery
2015;42(12):845-848
- CountryChina
- Language:Chinese
-
Abstract:
For recently 30 years,with the progress of science,the development of intracavitary technology has been constantly improved and expanded.Reascularization technology makes the cure of vaso-occlusive disease a great leap.Because of its small trauma,repeatable,high security,near future curative effect,interventional therapy is distinctly superior to the traditional treatment such.Peripheral vascular lumen treatments including the balloon dilatation,stent-assisted angioplasty,catheter guided thrombolysis,and percutaneous mechanical thrombectomy,etc.Although angioplasty has become the best choice but the preferred treatment has limitations,such as for long and severe calcification of arteries occlusion surgery is difficult,immediate and long-term patency rate is low,the postoperative complications is frequent;Used for plaque ulcer and potentially thromboembolic disease,body highly risks of distal embolization;Inherent retraction force for postoperative lumen,intimal inflammation restenosis,stent thrombosis cause problems frequently.However,the percutaneous mechanical thrombectomy system is aimed at solving the clinical problems with good combination of engineering and technology research.The purpose of this paper is to expound the existing mechanical embolus removal system:SilverHawk/TurbjHawk aod Straub Rotarex thrombus,that is to elaborate its development status and clinical analysis.